-+ 0.00%
-+ 0.00%
-+ 0.00%

DataMeds AI Files Draft Information Statement

PUBT·11/16/2026 13:43:38
Listen to the news
DataMeds AI Files Draft Information Statement
  • DataMeds AI shareholders authorized common share issuance upon conversion of a $1.36 million convertible promissory note held by Axe Compute.
  • Issued September 11, 2026, as consideration for the Helomics acquisition, the note carries 7% annual simple interest.
  • The principal converts into 1,363,672 shares at the initial $1 conversion price; unpaid accrued interest may generate additional shares.
  • Conversion becomes automatic when shareholder approval takes effect; qualifying lower-priced share issuances would reduce the conversion price, increasing potential dilution.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-051800), on November 13, 2026, and is solely responsible for the information contained therein.